Trazodone Hydrochloride NDC 52817-395

NDC codes

FDA NDC Directory

Product NDC (as listed)52817-395Labeler and product segments. Claims need a package NDC.

Product NDC at billing width52817-0395Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
52817-395-10	52817039510	100 TABLET, FILM COATED in 1 BOTTLE (52817-395-10)Marketed from Sep 3, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Trazodone Hydrochloride
Generic name (nonproprietary): trazodone hydrochloride
Active ingredients: Trazodone hydrochloride — 25 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: TRUPHARMA LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 072193
Marketing start: Sep 3, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 52817-395_203c92fc-3666-44b8-b89c-0b1acf94f137SPL ID 203c92fc-3666-44b8-b89c-0b1acf94f137SPL set ID a57da4f8-151d-4a74-8710-6158d1da3852RxCUI 2751852, 2751854UNII 6E8ZO8LRNM
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N452817039510 followed by a unit qualifier and the quantity

Package 52817-0395-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 3, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults . Trazodone hydrochloride tablets are a selective serotonin reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 072193

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 072193
Product	Strength	Form · route	Labeler	Product NDC
Trazodone Hydrochloride	Trazodone hydrochloride 100 mg/1	Tablet, Film coatedOral	Oxford Pharmaceuticals, LLC	69584-885
Trazodone Hydrochloride	Trazodone hydrochloride 75 mg/1	Tablet, Film coatedOral	TRUPHARMA LLC	52817-396